Voloridge Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.6M | Buy |
|
|||||
|
2025
Q2 | $10.8M | Buy |
|
|||||
|
2025
Q1 | $4.11M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.26M | Sell |
|
|||||
|
2024
Q1 | $2.61M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $224K | Sell |
|
|||||
|
2022
Q4 | $598K | Sell |
|
|||||
|
2022
Q3 | $1.3M | Sell |
|
|||||
|
2022
Q2 | $1.41M | Buy |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $622K | Sell |
|
|||||
|
2021
Q3 | $909K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $1.18M | Sell |
|
|||||
|
2020
Q3 | $4.29M | Buy |
|
|||||
|
2020
Q2 | $252K | Buy |
|